Skip to main content
OPTH logo
OPTH
(NASDAQ)
Optimi Health Corp.
$4.75-- (--)
Loading... - Market loading

Optimi Health (OPTH) Company Profile

Complete business overview, executive team, trading details, and corporate information.

Optimi Health Corp.
OPTHNasdaq Stock MarketHealthcareDrug Manufacturers - Specialty & Generic

About Optimi Health

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company also engages in farming, processing, and distribution of raw mushroom biomass, mushroom extracts, manufacturing of drug products, and mushroom supplements. It sells its products through Amazon marketplace and distributors/brokers, as well as online. Optimi Health Corp. was incorporated in 2020 and is based in Princeton, Canada.

Stock Details

ExchangeNasdaq Stock Market (NASDAQ)
CurrencyUSD - USD
TypeStock

Contact Information

Phone778-761-4551
Address
269 David Brown Way Princeton, BC V0X 1W0 Canada

Corporate Identifiers

CIK0002027329
CUSIP68405H308
ISINCA68405H3080

Leadership Team & Key Executives

Dane Stevens
Co-Founder, Chief Executive Officer, Chief Marketing Officer and Director
John James Wilson
Co-Founder and Chairman
Bryan Edward Safarik
Co-Founder, Chief Operating Officer and Director
Jacob Safarik
Interim Chief Financial Officer and Director
Dr. Preston A. Chase
Chief Science Officer
Ann Little
Human Resources Manager
Leah Hodges
Corporate Secretary